April 23, 2025 05:00 AM EDTUpdated 08:40 AM
Pharma
Law
Health Tech

Eli Lil­ly sues four tele­health com­pa­nies sell­ing com­pound­ed tirzepatide

Shelby Livingston

Health tech correspondent

Just a few weeks af­ter Eli Lil­ly sued two large com­pound­ing phar­ma­cies, the phar­ma gi­ant on Wednes­day filed law­suits against four tele­health …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bris­tol My­er­s' schiz­o­phre­nia drug fails Phase 3 tri­al for ad­junc­tive treat­ment

As­cle­tis posts puz­zling Phase 1 up­date on obe­si­ty pill

Chi­na’s biotech mar­ket is stag­ing a come­back that US biotech can on­ly wish for

Genen­tech vet launch­es ADC start­up with $20M

With aims to be­come a 'gen­er­a­tional biotech,' Zealand Phar­ma hires Lil­ly vet­er­an as sci­ence chief

sponsored

AD­STI­LADRIN® (nad­o­fara­gene fi­rade­n­ovec-vncg) – A Grow­ing Body of Clin­i­cal Da­ta and Re­al-World Ev­i­dence

A service from the Financial Times